September 23rd 2020, 1:00pm
Relapse at an older age can significantly contribute to a worsening of multiple sclerosis (MS), explained Burcu Zeyda, MD, assistant professor of neurology, assistant professor of radiology, at Mayo Clinic.
September 18th 2020, 9:00pm
Emerging data is showing that treatment within 6 months of presentation of multiple sclerosis (MS) is ideal, explained Patricia K. Coyle, MD, of Stony Brook University Neurosciences Institute.
September 11th 2020, 7:30pm
Results of a combined training program in 17 patients with multiple sclerosis indicate patients reap benefits from daily activities like walking or sitting-to-standing, and show the program reduces the dual-task cost of performing cognitive tasks while walking.
September 5th 2020, 4:15pm
The authors suggest that recognizing the possible link may help identify patients at greater risk, although they do caution that larger studies are needed.
September 4th 2020, 6:30pm
A small study says that gloves with sensors could measure impairments in hand function and may have advantages over standard methods.
August 29th 2020, 9:15pm
Patients were more likely to report more relapses of multiple sclerosis than physicians.
August 23rd 2020, 1:00pm
Adherence to multiple sclerosis (MS) therapy is linked with improved clinical outcomes, better quality of life, lower health care costs, and other benefits.
August 21st 2020, 12:00pm
For multiple sclerosis, the therapy will be sold as Kesimpta by Novartis; it is administered by patients once a month through the Sensoready autoinjector pen.
August 20th 2020, 3:30pm
A combination of delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD) relieved certain neurophysiological symptoms affecting patients with secondary progressive multiple sclerosis (MS).
August 15th 2020, 10:45am
Certain aspects of satisfaction with multiple sclerosis (MS) treatment can impact health-related quality of life (HRQOL).
